Study record

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Kim SJ, Xiao J, Cohen P et al. · J Vis Exp · 2017

CellsRelated mitochondrial peptideEvidence tier D

What this study reported

Described a cell-culture method combining subcellular fractionation and western blotting to quantify activation and translocation of signalling molecules such as ERK after mitochondrial-derived peptide treatment. The abstract notes that signalling mechanisms of MOTS-c and SHLPs had yet to be elucidated and reports no MOTS-c-specific results.

Limitations

Methods video article; the abstract reports no MOTS-c data, and it is unclear which peptides were tested.

Study record

Annotated fields for this study
Study modelCell study (in vitro)
Substance studiedRelated mitochondrial peptideThe paper is mainly about another mitochondrial-derived peptide, such as humanin.
Specieshuman
System studiedCell culture subcellular fractionation and western blotting protocol (HEK293 cells per MeSH)
PopulationNot reported
DesignMethods protocol (cell culture)
Sample size as reportedNot reported
Control groupNot reported
Route (data field only)in-culture
Endpoints measuredERK activation; nuclear translocation of signalling molecules
Pathways measuredMAPK signalling · Nuclear translocation
Research areasMethods
Evidence tierD — Cell, tissue or analytical
Publication typesJournal Article, Video-Audio Media

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Peripheral
Model applicability
Cellular
Sample size
n/a
Controls
n/a
Outcome validity
Exploratory
Support for its own conclusion
n/a

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.